Immediate Impact
54 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
Works of Yuzhou Gui being referenced
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial
2023
MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yuzhou Gui | 167 | 58 | 18 | 75 | 63 | 17 | 380 | |
| Wei‐Bang Yu | 149 | 26 | 12 | 91 | 25 | 15 | 377 | |
| Yucai Chen | 167 | 54 | 9 | 42 | 35 | 24 | 408 | |
| Xiawen Yang | 205 | 43 | 3 | 35 | 49 | 24 | 442 | |
| Susumu Tomono | 206 | 38 | 3 | 48 | 96 | 31 | 405 | |
| Jun‐Hua Xiao | 186 | 39 | 77 | 40 | 22 | 24 | 453 | |
| Xiaohui Zheng | 210 | 46 | 8 | 26 | 22 | 23 | 424 | |
| Hui Yu | 166 | 29 | 18 | 24 | 46 | 26 | 403 | |
| Qingyu Zhang | 190 | 66 | 5 | 43 | 38 | 24 | 431 | |
| Elvira Ventura-Spagnolo | 95 | 36 | 5 | 116 | 31 | 10 | 403 | |
| Yonghui Lv | 138 | 18 | 4 | 45 | 55 | 19 | 360 |
All Works
Loading papers...